A double-blind, placebo-controlled trial of clonazepam in obsessive–compulsive disorder
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Selective serotonin reuptake inhibitors (SSRIs) are currently the first-line pharmacological agents in treating obsessive-compulsive disorder (OCD). Appropriate treatment for OCD also involves cognitive behavioural therapy (CBT), including exposure and response prevention. As there is a time delay in seeing full therapeutic response, and not all patients tolerate SSRIs, there remains an unmet need for additional treatment approaches in OCD. In addition, most responders report only a partial reduction in symptoms. Clonazepam has demonstrated effectiveness in several preliminary reports in treating OCD. Twenty-seven patients with OCD were entered into a 10 week, double-blind, parallel design trial of clonazepam vs. placebo. Overall, only 3 out of 25 patients who had >/= 1 rating on clonazepam/placebo were judged to be treatment responders, by scoring a 1 (very much improved) or 2 (much improved) on the CGI improvement scale. Responders included 2 of 9 in the placebo group and 1 of 16 in the clonazepam group. No significant difference was found between clonazepam and placebo groups on responder/non responder status (Chi(2 )=1.39, df =1,24, p=0.238), nor on change in YBOCS, Ham-A, Ham-D or NIMH scales from beginning to last evaluation carried forward. These findings suggest that clonazepam is not effective as monotherapy in treating OCD. Its effectiveness in specific subgroups of OCD patients with co-morbid anxiety disorders or as an augmentation strategy added to SSRIs remains to be determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“if the therapeutic effect of OCD is through anxiety reduction, then one would expect benzodiazepines to have a positive effect in OCD, which they do not (Hollander et al., 2003, Bartz and Hollander, 2006).”
From The role of habit in compulsivity (2016) · cites this paper as Hollander et al., 2003
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
The Epidemiology of Obsessive-Compulsive Disorder in Five US Communities
Karno, M. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800360042006 · Cited by 1,351
Compulsive buying: descriptive characteristics and psychiatric comorbidity.
Ga, C., Faber, R., de Zwaan, M., Raymond, N. C., Sm, S., Ekern, Tb, M., Crosby, R. D., Sj, C., & Ed, E. (1994) · PubMed · Cited by 664
Weissman, M. M., Bland, R. C., CANINO, G. J., Greenwald, S., Hwu, H., Lee, C. K., Newman, S. C., Oakley‐Browne, M., Rubio-Stipec, M., & WICKRAMARATNE, P. J. (1994) · PubMed · Cited by 486
Clomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder
(1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320054008 · Cited by 388
Treatment of Social Phobia With Clonazepam and Placebo
DAVIDSON, J. R. T., POTTS, N., RICHICHI, E., KRISHNAN, R., FORD, S. M., SMITH, R., & WILSON, W. H. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312000-00008 · Cited by 265
CHADWICK, D., HALLETT, M., HARRIS, R., JENNER, P., REYNOLDS, E. H., & MARSDEN, C. D. (1977) · Brain · doi:10.1093/brain/100.3.455 · Cited by 210
Multivariate Meta-Analysis of Controlled Drug Studies for Obsessive-Compulsive Disorder
Ackerman, D. L., & Greenland, S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00012 · Cited by 202
Pivotal studies of clonazepam in panic disorder.
Davidson, J. R. T., & Moroz, G. (1998) · PubMed · Cited by 173
Montgomery, S. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90266-o · Cited by 172
Research works printed but not linked: 7
- Bacher N H, 1990, J Clin Psychiatry, 51, 168
- Bodkin J A, 1989, J Clin Psychiatry, 50, 265
- Davidson J R, 1998, Psychopharmacol Bull, 34, 169
- Hewlett W A, 1990, J Clin Psychiatry, 51, 158
- Ross D C, 1993, J Am Acad Child Adoles Psychiatry, 32, 470
- Wagner H R, 1986, Adv Neurol, 43, 645
- Weissman M M, 1994, J Clin Psychiatry, 55, 5
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“Adjunctive risperidone [755-761] 1* Clonazepam [771] 2 (-ve)”
Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment
Hirschtritt, M. E., Bloch, M. H., & Mathews, C. A. (2017) · JAMA · doi:10.1001/jama.2017.2200 · Cited by 493
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
The role of habit in compulsivity
Gillan, C. M., Robbins, T. W., Sahakian, B. J., van den Heuvel, O. A., & van Wingen, G. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.033 · Cited by 292
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
Del Casale, A., Sorice, S., Padovano, A., Simmaco, M., Ferracuti, S., Lamis, D. A., Rapinesi, C., Sani, G., Girardi, P., Kotzalidis, G. D., et al. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180813155017 · Cited by 223
Metadata
- Authors
- Hollander, E., Kaplan, A., & Stahl, S. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- University of California San Diego (US)
- Corresponding author
- Hollander, Eric
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 30-34
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2050637887
- Cited by
- 97
- References
- 23
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2018: 6 · 2017: 5 · 2016: 3 · 2015: 9 · 2014: 3 · 2013: 5 · 2012: 9
- FWCI
- 8.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Georgetown University
- University of California, San Diego
- School of Medicine, University of California, San Diego
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- clonazepam, obsessive-compulsive disorder, benzodiazepines, treatment response, monotherapy, selective serotonin reuptake inhibitors, augmentation therapy, anxiety comorbidity
- MeSH terms
- Adult, Aged, Anticonvulsants, Clonazepam, Double-Blind Method, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder, Severity of Illness Index, Cognitive Behavioral Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double-blind, placebo-controlled trial of clonazepam in obsessive–compulsive disorder. https://app.cochat.ai/papers/10.3109/15622970309167908
- The paper
- Hollander, E., Kaplan, A., & Stahl, S. M. (2003). A double-blind, placebo-controlled trial of clonazepam in obsessive–compulsive disorder. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622970309167908
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.